Abstract

Background and Aims: Stroke is a major public health problem worldwide. The risk of recurrence is highest in the first year after the stroke, majority of the recurrent cases are due to atherosclerosis of the large arteries. The present study was conducted to evaluate clinico-bio-demographic profile of recurrent stroke patient in respect of risk factor and secondary prevention of stroke. Methods: A hospital-based cross-sectional study was conducted on 300 recurrent ischemic/hemorrhagic stroke (age 18-85 yrs.) from August 2015 to March 2017. Stroke mimic were excluded. Risk factors studied were hypertension, diabetes mellitus, hyperlipidemia, cardiac causes and cigarette smoking. Results: Mean age of recurrent stroke was 60±13 years with male preponderance (M: F≤5.3). Ischemic stroke was found in 93% cases. About one third (33%) patients had their first recurrence within three months of index stroke. Active smoking, uncontrolled hypertension and diabetes were found in 71%, 62%, and 65 % cases respectively. There was association between first ever stroke and recurrence showing P value > .05, <.001 and <.01 for uncontrolled hypertension, diabetes and active smoking respectively. Extra cranial stenosis (>70%) was found in 29% of recurrent stroke. Out of all stroke cases 40% were drug defaulters. Conclusions: In our study commonest cause of recurrent stroke was active smoking followed by uncontrolled diabetes, uncontrolled hypertension, poor drug compliance and symptomatic carotid stenosis. Frequency of recurrence was more within 3 months.

Keywords: Atherosclerosis · Drug adherence · Extra cranial stenosis · Risk factors · Recurrent stroke

References

  1. 1.Pandian, Jeyaraj Durai et al.Secondary prevention with a structured semi-interac­ tive stroke prevention package in INDIA (SPRINT INDIA): a multicentre, ran­ domised controlled trial.The Lancet Global Health 11(3), e425-e435. 3 Johnston SC, Rothwell PM, Nguy­ en-Huynh MN, Giles MF, Elkins JS, Bern­ stein AL, Sidney S. Validation and refine­ ment of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007 Jan 27;369(9558):283-92.
  2. 2.Lovett JK, Coull AJ, Rothwell PM: Early risk of recurrence by subtype of ischemic stroke in population-based incidence stud­ ies. Neurology 2004; 62: 569-573
  3. 3.Leoo T, Lindgren A, Petersson J, Von Arbin M. Risk factors and treatment at re­ current stroke onset: results from the recur­ rent stroke quality and epidemiology Stroke 2004; 35: 731 735.
  4. 4.Rangamani, Sukanya et al. Stroke inci­ dence, mortality, subtypes in rural and urban populations in five geographic areas of India (2018-2019): results from the National Stroke Registry Programme.The Lancet Re­ gional Health - Southeast Asia 23,100308.
  5. 5.Nagaraja D, Gururaj G, Girish N, Panda S, Roy AK, Sarma GR, Srinivasa R. Feasibil­ ity study of stroke surveillance: data from Bangalore, India. Indian J Med Res. 2009 Oct;130(4):396-403. PMID: 19942742.
  6. 6.Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005 Oct 25;112(17):2735-52.
  7. 7.Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Pe­ ripheral Vascular Disease. Guidelines for the (RESQUE) study. Cerebrovasc Diseases 2008; 25:254-260.
  8. 8.Hardie K, Hankey GJ, Jamrozik K, Broad­ hurst RJ, Anderson C: Ten-year risk of first prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Associ­ recurrent stroke and disability after firstever stroke in the Perth Community stroke study. ation. Stroke. 2014 Jul;45(7):2160-236.
  9. 9.North American Symptomatic Carotid Clinicodemographic Profile Of Recurrent Stroke And Secondary Prevention At Tertiary Care Centre Of North-West India Majmaah Journal of Health Sciences , Volume 12 Issue 4 October 2024, Rabi Al-Awwal 1446 Endarterectomy Trial Collaborators high-grade carotid stenosis. N Engl J Med. 1991;325:445-453
  10. 10.Kocaman G, Duruyen El, Kocer A, Asil T. Recurrent ischemic stroke characteristics and assessment of sufficiency of secondary stroke prevention. Noro Psikiyatri Aryivi. 2015 Jun;52(2): 139.
  11. 11.Laloux P, Lemonnier F, Jamart J. Risk factors and treatment of stroke at the time of recurrence. Acta Neurologica Belgica. 2010 Dec l;110(4):299.
  12. 12.Kavian Ghandehari, Khajedaluei R.M, Zehra Yazdankhah,Kosar Ghandehari. Risk factor of short-term stroke recurrence in pa­ tients with minor ischemic cerebrovascular events. ARYA Atheroscler 2013; 9(2) : 119-127.
  13. 13.Burn J, Dennis M, Bamford J, Sander­ cock P, Wade D, Warlow C. Long-term risk
  14. 14.Wasay M, Khatri IA, Kaul S. Stroke in South Asian countries. Nat Rev Neurol 2014;10:135-43.
  15. 15.Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive dis­ ease: a large worldwide burden but a rela­ tively neglected frontier. Stroke. 2008;39:2396-2399.
  16. 16.Al AlShaikh S, Quinn T, Dunn W, Wal­ ters M, Dawson J. Predictive factors of non-adherence to secondary preventative medication after stroke or transient isch­ aemic attack: A systematic review and meta-analyses. European Stroke Journal. 2016 Jun;l(2):65-75.
  17. 17.Arif H, Aijaz B, Islam M, Aftab U, Kumar S, Shafqat S. Drug compliance after stroke and myocardial infarction: A compar­ ative study. Neurol India 2007;55:130-5. of recurrent stroke after a first-ever stroke. Stroke 1994; 25:333-337.
  18. 18.Nete Hornnes ,Klaus Larsen , Gudrun Boysen. Little change of modifiable risk factor 1 year after stroke: a pilot study IJS 2010; 5(6): 157-162
  19. 19.Kaplan RC, Tirschwell DL, Longstreth WT Jr, Manolio TA, Heckbert SR, Lefkowitz D, El-Saed A, Psaty BM. Vascular events, mortality and preventive therapy following ischemic stroke in the elderly. Neurology 2005 Sep 27; 65(6):835-842.
  20. 20.Amarenco P, Goldstein LB, Szarek M, Sillesen H, Rudolph AE, Callahan A et.al. Effects of intense low-density lipoprotein cho-lesterol reduction in patients with stroke or transient ischemic attack. Stroke. 2007;38:3198-3204. Clinicodemographic Profile Of Recurrent Stroke And Secondary Prevention At Tertiary Care Centre Of North-West India

Peer review

Peer reviewed by 3 reviewers, who chose to remain anonymous.

Majmaah Journal of Health Sciences · eISSN 1658-8223 · Majmaah University · open access